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VITAMIN K AND PROTHROMBIN
CHAPTER I
INTRODUCTION
The nutrition and metabolism of vitamin K have been investi­
gated extensively in the last twenty-five years, and the major emphasis 
of most of these investigations has been with the vitamin K requirement 
for haemostasis. The original observations relating vitamin K and blood 
clotting (1) came from studies of chicks raised on a fat free diet which 
developed superficial and internal bleeding. The search for a lipid 
substance in the diet capable of reversing these hemorrhagic symptoms 
led to the isolation and characterization of the naturally occurring _  ̂
forms of vitamin K. When the original observations were made there was 
no knowledge of the type of alteration in blood clotting responsible for 
the observed hemorrhagic tendencies. The view persisted for some time 
(2) that an inhibitor of the clotting process was present in the plasma 
of vitamin K deficient animals.
A definitive experiment to distinguish between lowered levels 
of clotting factors and the presence of inhibitors of clotting (3) dem­
onstrated that plasma from deficient animals clotted normally when a 
prothrombin preparation was added, but active prothrombin could not be 
obtained from plasma of deficient animals. This evidence supported the
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idea that a dietary deficiency of vitamin K lowered the levels of clot­
ting factors in plasma.
Hemorrhagic tendencies correlated with obstructive jaundice 
and experimental bilary fistulas were recognized to result from impair­
ment of absorption of the vitamin (4) and symptoms disappeared when vi­
tamin K was given by injection. Since these clotting changes in birds 
and mammals were readily corrected by administration of vitamin K it 
was proposed (5) that the lack of prothrombin is the only immediate re­
sult of vitamin K deficiency and hence the sole cause of bleeding in the 
deficient state.
With the advent of the coumarol series of vitamin K antago­
nists, and, as knowledge of the process of blood clotting increased, it 
became apparent that vitamin K is involved in factors affecting prothom- 
bin activation as well as in prothrombin formation (6). Tests for vita­
min K dependency of new blood clotting factors have been applied as 
these new factors have been characterized (7) and the so called "pro­
thrombin group" of factors derive their name from a common sensitivity 
to vitamin K antagonists. Thus, according to the system of nomencla­
ture adopted by the International Committee for Haemostasis and Throm­
bosis, factors II, X, IX and VII are all dependent on adequate amounts 
of dietary vitamin K.
Of these four factors only factor II (prothrombin) has been 
purified to the extent of satisfying physicochemical criteria of homo­
geneity (8). Some controversy exists in the literature as to the inde­
pendent existence of these factors (9), or their common origin as inter­
mediates produced during, and mediating the autocatalytic activation of
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prothrombin (10). However, the enigma of vitamin K action remains 
whether the factors affected be one, or four, in number.
One of the earlier hypotheses to arise as to the effect of 
vitamin K on clotting activity (11) proposed that a possible function 
could include the vitamin as a prosthetic group on the prothrombin mole­
cule. The more recent evidence for vitamin K mediated control of the 
levels of four independent clotting factors makes this hypothesis seem 
less probable. Also it is known that a thorough investigation of pro­
thrombin using both chemical and biological assays (12) fails to reveal 
any evidence for the presence of vitamin K.
A more recent idea put forth to explain the action of vitamin 
K (13) proposes an involvement of napthoquinones in coupling electron 
transport and oxidative phosphorylation. This theory proposes that the 
"prothrombin group" of clotting factors have a very short half-life in 
vivo, and the first manifestations of a decrease in the efficiency of 
energy production could be seen as a lowered level of these factors. 
Inherent in this model are the following premises: (1) in vitro studies
would be expected to show decreased P/0 ratios in mitochondrial prepa* 
rations from deficient animals, (2) protein synthesis in these animals 
would be expected to be proceeding at a decreased rate as compared to 
controls.
Martius reported a decrease of one-third in P/0 ratios of mito­
chondria isolated from the liver of chicks deficient in vitamin K. Sub­
sequent investigators (14) were not able to detect this decrease in P/0 
ratio, and it is generally accepted now that some vitamin K antagonists 
do exist which have no effect on mitochrondrial respiration, and a lack
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of vitamin K does not alter this respiration. Failure to demonstrate 
any effect of vitamin K deficiency on _in vivo incorporation of labelled 
amino acids into protein (15) or the dietary induction of tryptophan 
pyrrolase indicates a lack of any general effect of vitamin K on protein 
metabolism.
Since all the information seems to indicate that vitamin K 
specifically affects only the prothrombin group of proteins, attention 
has been focused on the individual steps in protein synthesis where 
control mechanisms could be expected to function. The proposal of the 
"Operon Hypothesis" (16) suggested new ways in which the vitamin could 
regulate the synthesis of one or several specific protein molecules by 
a derepressor-like function. The availability of antibiotics which 
specifically block individual steps in protein synthesis provided new 
ways of studying the synthesis of prothrombin which occurs when vitamin 
K is given to deficient or dicoumarol treated animals. The first exper­
iments to be reported using these new methods (17) showed that it was 
possible to give vitamin K deficient chicks a large enough dose of acti- 
nomycin D to prevent the normal recovery of prothrombin levels observed 
after menadione administration, when measurements of prothrombin level 
were made 6 hours after the administration of actinomycin D.
It is readily apparent that information from control animals 
administered equivalent doses of actinomycin D must be obtained in order 
to interpret these results. The biological half-life of the individual 
proteins, the half-life of the message RNA coding for the synthesis of 
the proteins, and the particular clotting factors measured in the assay 
procedure could all influence the final result.
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At the time this experiment was carried out there was no in­
formation available on the half-life of prothrombin in the chick. Data 
on the prothrombin group obtained from human subjects treated with the 
vitamin K antagonist, 4-hydroxy coumarin (7) indicate half-lives of 60,
5, 30 and 45 hours for factors II, VII, IX and X respectively. It is 
known, however, that coumarol derivatives and vitamin K seem to compete
with each other, and certainly it is not practical to give human sub­
jects large enough doses of vitamin K antagonists to completely block 
prothrombin synthesis even if such a treatment is possible. Probably a 
better means of estimating the half-life of clotting factors (18) in­
volves measuring the disappearance of prothrombin administered to hypo­
prothrombinémie patients. In these conditions a rapid turnover corres­
ponding to a nine hour half-life was observed.
When rats were given doses of actinomycin D sufficient to 
block prothrombin synthesis _in vivo (19) a rapid drop in blood prothrom­
bin level was observed, and the half-life appears to lie in the range of 
five to eight hours. Interpretation of these data is rendered difficult
due to the necessity for considering the half-life of the message RNA
involved - therefore, the estimates probably represent a maximum half- 
life.
If both prothrombin and its message RNA turn over quite rapidly 
any synthesis of prothrombin occurring in the presence of actinomycin D 
must be measured before pre-existing message decays. Data obtained from 
this type of experiment indicate that vitamin K-dependent induction of 
prothrombin synthesis does occur in actinomycin D treated animals. The 
absence of any vitro effects of vitamin K on the clotting ability of
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plasma obtained from vitamin K-deficient animals, and other lines of 
evidence (20) indicate that vitamin K-dependent clotting factor activity 
requires ̂  novo clotting factor synthesis. This view has been substan­
tiated by experiments using puromycin (21) which show insignificant 
amounts of prothrombin synthesis after giving vitamin K to deficient, 
puromycin-treated animals. Jja vitro studies on synthesis of another 
member of the prothrombin group using liver slice techniques (22) sup­
port the vivo findings.
It seems fairly clear that protein synthesis is required in 
order to obtain a response to vitamin K. Now the question must be asked, 
"Is vitamin K required for the specific novo incorporation of amino 
acids into a polypeptide ultimately destined to become a member of the 
prothrombin group?" We must have an answer to this question if we are 
to produce a precise operational model for the control of synthesis of 
specific proteins. It should be noted that the requirement for protein 
synthesis in the production of prothrombin activity cannot be taken as 
evidence for a direct role of vitamin K in controlling the synthesis of 
the prothrombin group. Several other explanations are possible, and a 
few of the more plausible ones are considered below.
All members of the prothrombin group are probably glycoproteins. 
Vitamin K could have a role in the synthesis or attachment of a carbohy­
drate moiety required for enzymic and immunological activity. There is 
little evidence in the literature to support such a view. Although pur­
ified prothrombin is reported to contain 5 to 6% neuraminic acid by 
weight (23), complete removal of the neuraminic acid by treatment with 
clostridial neuraminidase was accompanied by only a 30% decrease in
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prothrombin activity. It was proposed that this inhibition could be due 
to residual proteolytic activity known to exist in the neuraminidase 
preparation. These data indicate that enzyme activity which depends on 
carbohydrate moieties would have to depend on sugar residues other than, 
and independent of attachment to neuraminic acid.
Vitamin K could act in joining subunits together such that the
proper quaternary structure required for enzymic activity is produced.
It is known that dogs treated with clinical doses of dicoumarol (24) do
not possess significant amounts of cross-reacting material to prothrombin
antibody. If prothrombin were composed of immunologically unreactive 
subunits, then these could be present in plasma lacking prothrombin (25), 
and their proper assembly could involve alignment requiring vitamin K, 
or an enzyme containing vitamin K as a prosthetic group. Prothrombin 
preparations have been reported (26) with a mean of sixteen disulfide 
bonds per molecule. The degree of complexity present in such a system 
could necessitate an enzyme which catalyzes correct pairing. Vitamin K 
is known to complex with free sulfhydryl groups (27). The most powerful 
objection to this hypothesis is the failure of vitamin K to produce pro­
thrombin activity _in vitro in plasma from deficient animals which lacks 
this activity. Data now in press (28) reinforce the idea that neither 
free vitamin K nor any protein bound form of the vitamin occurring in 
situ demonstrate this type of activity.
The evidence does seem to indicate a functional form of vitamin 
K which is modified in some manner from that of the free vitamin.
Estradiol can replace vitamin K requirements for haemostasis 
(29) in rats, and the enzymic binding of estradiol and some of its
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structural analogues to proteins has been documented (30). Thus it is 
possible that a similar type of binding could be occurring between vita­
min K and an apoenzyme to produce a species required for clotting factor 
synthesis. If this binding were of a specific nature, then it should be 
possible to detect an enzyme containing vitamin K as a prosthetic group 
by investigating the distribution of radioactively labelled vitamin K 
administered to deficient animals.
Protein binding of estradiol appears to be mediated through 
free radical production via the NADPH microsomal oxidation pathway (30). 
Unfortunately this type of reaction is neither completely enzymic nor 
very specific and binding produced will be quite random. If vitamin K 
is bound as a prosthetic group on an enzyme it might not be detectable 
using radioactive tracers due to non-specific binding to many species 
of cell protein.
With an awareness of these limitations there may still be some 
value in checking the intracellular distribution of vitamin K, especially 
of the naturally occurring dietary vitamin Kĵ .
The object of this study was to conduct a series of experiments 
which could give evidence to support a hypothesis of vitamin K action 
consonant with the known facts about this system, yet avoiding the diffi­





Urea, imidazole, tris (hydroxymethyl) amino methane, reduced 
glutathione, bovine pancreatic ribonuclease A, and dextran with molecu­
lar weight of 60,000 to 80,000 were purchased from the Sigma Chemical 
Company, St. Louis, Missouri.
The Aldrich Chemical Co. Inc. were suppliers of 2-mercapto- 
ethanol, 40% aqueous methylamine, and 5,5*-dithiobis-2-nitrobenzoic acid 
(DTNB).
Dithiothreitol (Cleland's Reagent) was purchased from Calbio-
chem.
Sodium warfarin and dehydroascorbic acid were bought from 
K and K Laboratories, Inc., Plainview, N. Y.
Commercially available materials used routinely in the clot­
ting assay include: fibrinogen (Cohn fraction I) citrated, obtained as
a dry powder containing 60% protein with about 67% of the protein clot- 
table from Sigma Chemical Corp., a lyophilyzed human plasma (Diagnostic 
Plasma) obtained from General Diagnostics Division of Warner-Chilcott, 
Morris Plains, N. J., and bovine thrombin preparations of standard con-
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centration sold as Thrombin Topical by Parke, Davis Co., Detroit, Mich, 
Bovine serum which has been kept with the clot for thirty 
hours at 24° C, and then 18 hours at 4° C was used as a source of fac­
tors V, VII and X. This material was stored at -15°G, and quick-thawed 
before use.
Different forms of Sephadex (a registered trademark of the 
Pharmacia Co., Uppsala, Sweden) used for dialysis and ion exchange pro­
cedures, including Sephadex G-25, carboxymethyl (CM)-Sephadex and diethyl- 
aminoethyl (DEAE)-Sephadex, have been purchased from the Sigma Chemical 
Corp. .
Ultrafiltration 
A Sartorius Membranfilter has been used for ultrafiltration.
The membrane in this apparatus is a collodion bag with pore size of less 
than 50 millimicrons. A product of West Germany, it is marketed in this 
country by Carl Schleicher and Schuell, Keene, N. H.. The approximate 
molecular exclusion size of the 50 millimicron pores corresponds to a 
molecular weight of about 30,000.
Ultrafiltration has also been carried out using membranes 
which are hydrous gels of the complex interaction product of polyanions 
and polycations and are marketed under the name Diaplex by the Amicon 
Corp., Cambridge, Mass.. Solvent flow through these membranes is said 
to occur by a process of true molecular diffusion (31) as opposed to 
hydraulic pore flow observed in conventional ultrafilters. Various 
upstream surface formulations are available to allow screening of solute 
molecules of different molecular weight or charge.
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Rats
Male albino rats weighing 60-80 grams were purchased from 
Sprague-Dawley of Madison, Wisconsin. These rats were maintained on 
purified diets containing adequate levels of all nutrients known to be 
required, with the exception, where indicated, of vitamin K.
Experimental Diets 
The diet used is known to be inadequate (32) with regard to 
vitamin K content. When coprpphagy is prevented, male rats maintained 
on this diet develop severe hemorrhagic symptoms, and usually die within 
5-10 days of the beginning of coprophagy restriction. For composition 
of the diet refer to Table 1. Methionine was purchased from the Sigma 
Chemical Co., sucrose was a commercial product obtained locally, and 
the remainder of the constituents were purchased from the Nutritional 
Biochemicals Corporation, Cleveland, Ohio. Control rats were maintained 
on the above diet supplemented with 1.0 grams of menadione per 100 grams 
of vitamin premix or on a commercial pellet diet obtained from Rockland 
Laboratories, Teckland Inc., Monmouth, Illinois.
Coprophagy Prevention 
When vitamin K deficient rats were required, animals with a 
weight range of 160 to 180 grams which had been maintained on the vita­
min K deficient diet were selected. These animals were placed in tub­
ular coprophagy-preventing cages (33) and left for four days. Then the 
whole blood clotting time was measured by the single stage method as an 
index (34) of vitamin K depletion. Varying degrees of clotting activity 
reaching as low as ten percent of normal have been present in rats used
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TABLE I
COMPOSITION OF THE VITAMIN K DEFICIENT DIET
Constituent Weight Percentage of 
the Total Diet
Sucrose 66,9




Vitamin premix (in cerelose)* 3.0
Salt mixture #446 (Nutritional Biochemicals) 4.0
100.0
*VITAMIN PREMIX
Constituent Amount Present in 100 gm 
of Cerelose-Premix
Thiamin hydrochloride 4.0 mg
Riboflavin 4.0 mg
Calcium pantothenate 20.0 mg
Pyridoxine 3.0 mg
Nicotinic acid 40.0 mg
Biotin 0.04 mg
Folic acid 0.4 mg
Vitamin B%2 (0.1% in mannitol) 20.0 mg
Choline chloride 200.0 mg
Vitamin A 4000 I.U.
Vitamin D 400 I.U.
Vitamin E (0(-tocopherol succinate) 60.0 mg
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in this study. Daily measurement of clotting activity was usually suffi­
cient for obtaining deficient animals before death occurs by internal 
hemorrhage.
Methods
Krebs-Ringer Buffer Preparation 
Krebs-Ringer buffer was prepared from the following components:
1) 0.9% NaCl 100 parts
2) 1.15% KCl 4 parts
3) 2.11% KHgPO^ 1 part
4) 3.82% MgSO^ • 7H2O 1 part
5) 1.30% NaHCOg (gassed with COg,) 21 parts
This buffer was made up freshly each day before use, and gassed with 5% 
COg, 95% Og for ten minutes to increase the level of dissolved carbon 
dioxide.
Prothrombin Assay 
The two-stage assay procedure (35) for the measurement of pro­
thrombin in defibrinated plasma has been slightly modified for the assay 
of isolated prothrombin. Reagent solutions used in the assay are listed 
below:
1) A 0.9% solution of NaCl in distilled water.
2) Imidazole buffer pH 7.2, prepared by dissolving 1.75 grams of dry
imidazole in 90 ml of 0.1 N HCl and adjusting the volume to 100 ml with 
distilled water.
3) A 14% w/v solution of dextran in 0.9% NaCl.
4) Thromboplastin and calcium solution which was purchased in the lyoph-
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ilized form as ”Simplastin”, and dissolved in distilled water as specif­
ied.
5) "Accelerator globulin" solution which was prepared from the specially 
treated serum listed under materials by diluting 8 parts of serum with 
0.9% NaCl to a total of 1000 parts.
6) Fibrinogen solution was prepared by dissolving the commercial pro­
duct in a mixture of 9 volumes 0.9% NaCl and 1 volume of imidazole buffer, 
to obtain a final concentration of 1% on the basis of clottable protein.
The prothrombin preparation to be assayed was diluted in the 
"accelerator globulin" solution, and the assay procedure carried out as 
follows:
Mixture A
14% dextran in physiological saline 2 parts
imidazole buffer pH 7.2 1 part
physiological saline 1 part
Mixture B
mixture A (above) 1 part
thromboplastin-calcium solution 1 part
Mixture C
mixture B (above) 2 parts
diluted prothrombin 1 part
Prothrombin was activated to thrombin in this mixture. After a seven 
minute incubation at 37°C fibrinogen was added to the solution. 
Mixture D
mixture C (above) 3 parts
fibrinogen solution 1 part
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The interval of time elapsing between the addition of a sample of mix­
ture C to fibrinogen, and the formation of a measureable clot, was re­
corded as an index of prothrombin concentration. Clot formation has been 
measured mechanically on a "Fibrometer" manufactured and marketed by the 
Baltimore Biological Laboratory Division of Becton, Dickinson and Compa­
ny, Baltimore, Maryland. Measurement was based on the increase in vis­
cosity of the reaction mixture required to operate a microswitch stop­
ing a digital readout clock whose cycle was initiated when mixture D is 
made.
Prothrombin time is then related to prothrombin concentration 
by comparing with clotting times observed for known dilutions of bovine 
thrombin of known standard concentration. All the reagents are stored 
at <4°C in either plastic or siliconized glass containers before the 
assay.
Prothrombin Preparation
Prothrombin was isolated according to the procedure of Moore 
et al. (8) with only a few deviations from their published protocol.
The following is an outline of the procedure including some minor modi­
fications.
Fresh bovine blood was obtained at the time of slaughter from 
the Canadian Valley Packing Company of Oklahoma City.and diluted 1:8 
with 2.85% aqueous trisodium citrate. Cooling was started on the trip 
from the packing house to laboratory by packing the containers in ice. 
Plasma was prepared from six liter batches of blood, and either used 
immediately in the preparation, or stored at -20OC. Approximately three 
liters of plasma were used in an individual preparation, and all subse-
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quent steps were carried out at 4°C using plastic or siliconized glass 
containers.
Barium citrate adsorption. A barium citrate precipitate was 
formed by slowly adding 1.0 M BaCl2 (10 ml per 125 ml of plasma) to the 
citrated plasma with gentle stirring. Stirring was continued for 10 min­
utes, and the precipitate was collected by centrifuging at 3600 x g for 
25 minutes in 300 ml polycarbonate bottles. The supernate was discarded, 
and the precipitate stirred with a small volume of a 1:10 dilution of 
stock citrate-saline (9.0% NaCl and 0.2 M NagCgH^Oy • 2H2O in distilled 
water) until a uniform suspension was made up to one liter. The suspen­
sion was stirred for 10 minutes and then allowed to equilibrate for one 
hour. Barium chloride addition was repeated as before. Stirring was 
continued for ten minutes after the addition had been completed and then 
the mixture was allowed to stand undisturbed overnight. In the morning 
the barium citrate was collected again by centrifuging for 25 minutes 
at 3600 X g. Again the supernate was discarded, the precipitate resus­
pended in sodium chloride-citrate, and BaCl2 addition repeated.
Elution and dialysis. After one hour the barium citrate was 
collected for the third time, the supernate discarded, and about 30 ml 
of 0.2 M Na EDTA pH 7.40 were added to each of the four centrifuge jars. 
When the material had been uniformly suspended it was distributed among 
ten 14 inch sections of Visking dialysis tubing pretreated with boiling 
EDTA, and stored at 4°C in distilled water prior to use. The centrifuge 
jars were washed out with EDTA solution, and the wash was added to the 
dialysis bags to give a total volume of 400 ml (40 per bag).
The material was dialysed for 30 minutes against 360 ml of
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0.2 M EDTA, 360 ml of stock citrate-saline and 2880 ml of distilled 
water. Subsequent dialysis was carried out against 3.6 liters of 1:10 
30 minute intervals. Dialysis was continued overnight in the last change.
Ammonium sulfate precipitation. Ammonium sulfate was added as 
the saturated solution adjusted to pH 7.0 with concentrated NH^OH. Drop- 
wise addition of one volume of saturated solution was carried out while 
the solution was being stirred. Stirring was continued five minutes 
after addition was completed, and the precipitate was removed by centri­
fuging for 30 minutes at 3600 x g. A second volume of saturated ammonium 
sulfate was added to the supernatant slowly with constant stirring. The 
solution was allowed to stand for 30 minutes to allow complete salting 
out, and then it was centrifuged as before to collect the precipitated 
prothrombin. This precipitate was washed with 15 ml of 67% saturated 
(NH^^gSO^ solution and again collected by centrifuging for 30 minutes 
at 3600 X g. The combined precipitate from all the centrifuge tubes was 
dissolved in 45 ml of distilled water, placed in a section of dialysis 
tubing and dialysed overnight against 4 liters of deionized water with 
3-4 changes of dialysate. The pH of the water should lie between 6.0 
and 8.0, as the buffering capacity of the preparation was low at this 
stage.
Isoelectric precipitation. After testing to make sure all 
sulfate ion had been removed, the pH of the solution was adjusted to 
5.40 with 0.25% (v/v) HCl. The precipitated protein was removed by cen­
trifuging for 30 minutes at 3600 x g and the pH of the supernate adjusted 
to 4.60. After sitting for fifteen minutes the suspension was centri­
fuged for 10 minutes at 1000 x g to collect the prothrombin precipitate.
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Dialysis against phosphate buffer. The precipitate from the 
above step was dissolved in five ml of phosphate buffer (0.05 M in 0.1 
M NaCl, pH 6.86 t 0.02, I 0.2), transferred to a dialysis bag with a 5 
ml rinse, and dialysed against the same buffer for six hours. The 4 
liter dialysate volume was changed twice, after the second and fourth 
hours.
Adsorption with kaolin and bentonite. After dialysis the 
protein concentration was adjusted to 15 mg per ml by diluting with phos- 
phate buffer. Kaolin was added to the solution at a concentration of 
125 mg per ml, and the suspension was shaken in an iced Doubnoff incuba­
tor for 15 minutes. The kaolin was removed by centrifuging at 3600 x g 
for 15 minutes, and then bentonite was added to the supernate at a con­
centration of 10 mg per ml and the adsorption procedure repeated. After 
removal of the bentonite the material was placed in a plastic container 
and stored at -20^0.
Determination of protein concentrations. Two different methods 
were used for the determination of protein concentration, depending on 
the material to be analysed. If the presence of suspended non-soluble 
protein was suspected, as in a crude cell homogenate, then the method 
of Lowry ̂  al. (36) was used. Following purification procedures which 
remove most non-protein substances, concentrations were estimated by 
ultraviolet adsorption (37).
Disulfide reduction in prothrombin. Again two separate methods 
were used in reducing the disulfide linkages in prothrombin. The major 
method follows that of Givol ^  al. (38). Sufficient urea to make an 
eight molar solution was added slowly with stirring to a 1% solution of
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prothrombin in 0.05 M KHPO^", 0.1 M NaCl, pH 6.86 "t 0.02. As the proce­
dure was normally carried out this involves adding about 0.48 g of urea 
to 0.630 ml of 1% prothrombin solution. Then 4 ^ 1  of 2-mercaptoethanol 
and one drop of 5% aqueous methylamine were added, the tube was gassed 
with nitrogen, stoppered and left for 12 hours at 24°C. After sitting, 
the solution was acidified with a drop of glacial acetic acid, and placed 
on a 1 X 25 cm column of G-25 Sephadex previously equilibrated with 0.1 
N acetic acid. The column was eluted with the equilibrating acetic acid, 
and the effluent monitored on a Beckman-Spinco Model 135 Spectromonitor. 
Ultraviolet absorption at 280 and 260 nÿl&was recorded as the effluent 
passed through the instrument. It was also possible to measure ultra­
violet absorption at 240 nj^as a sensitive test for the presence of 2- 
mercaptoethanol.
The protein emerging in the void volume of the G-25 Sephadex 
was usually collected in two or three samples of 60 drop si%e. Collec­
tion was always stopped before the appearance of 2-mercaptoethanol, as 
measured by 240 m ^  absorption.
Free sulfhydryl groups present in the fractions of the column 
effluent were measured in a colorimetric reaction with 5,5'-dithiobis- 
2-nitrobenzoic acid (39). DTNB was used as a 2.0 mM solution in 0.05 M 
KHPO^" pH 6.86, and 0.20 ml of the reagent was added to 5.0 ml of sample 
or standard diluted with 0.05 M KHPO^" buffer. The optical density was 
read at 412 i^on a Beckman DB spectrophotometer after the reaction had 
gone to completion in fifteen minutes at 24°C. As developed here the 
assay was sensitive to as low as lO'^yl^moles of sulfhydryl residue.
Protein concentration in the individual tubes was measured
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from the ultraviolet absorbance at 260 and 280 m ^in a Beckman DB spec­
trophotometer, and the moles of sulfhydryl group per milligram protein 
were recorded.
The alternate method for reduction of disulfide bonds involved 
the use of dithiothreitol (40). A 1% solution of prothrombin was treated 
with an approximate sixty-fold molar excess of dithiothreitol (1.0 mg 
per ml) for 48 hours at 24°C. The flocculent precipitate formed was 
dissolved by adding urea, guanidine, or diluting with nine volumes of 
0.1 N acetic acid pH 2.8.
Storage of the reduced material was carried out by maintaining 
it at a concentration of 1 mg per ml in 0.1 N acetic acid under a nitro­
gen atmosphere at 4°C. No attempts have been made to store such material 
for a period longer than two weeks.
Reactivation of Reduced Prothrombin
Reactivation experiments were carried out in Krebs-Ringer 
buffer modified by the omission of Cat^ ions which interfere with the 
clotting assay. This limitation prevented large modifications of the 
pH or ionic strength of the reaction mixture. Krebs-Ringer buffer 
contained:
0.9 % NaCl 100 parts
1.15% KCl 4 parts
3.82% MgSO^ • THgO 1 part
2.11% KHgPO^ 1 part
1.30% NaHCOg 21 parts
Stock solutions were stored at 4°C to minimize bacterial growth. The 
buffer was made up freshly before use, and gassed for ten minutes with
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a mixture of 95% O2 5% CO2. The pH was 7.0 after the freshly made buffer 
was saturated with carbon dioxide and held at a temperature below 4°C.
The total reaction volume in the reactivation system was 2.10 ml unless 
otherwise noted. All additions to the system such as enzyme fractions 
and cofactors were diluted in 2.0 ml of the Krebs-Ringer buffer, and 0.10 
ml of the reduced prothrombin preparation was added to obtain the final 
volume. Control tubes contained the reduced prothrombin, but no enzyme. 
These initial steps were carried out with all fractions in an ice bath.
Zero time values were obtained by removing 0.5 ml from each 
reaction mixture before incubation, and assaying for prothrombin. For 
incubation, the entire reaction mixture remaining was placed in a Doub- 
noff shaking incubator maintained at 37°C under an atmosphere of 95% O2 
and 5% CO^. After the prescribed incubation period the tubes were re­
moved from the water bath and placed on ice until aliquots could be 
removed for analysis.
Assay for Reactivation
Half ml aliquots of the reaction mixture were removed before 
and after the incubation. These aliquots were then added to a source of 
factors V, VII and X prepared by diluting bovine serum (prepared as de­
scribed earlier) fifty times in physiological saline. One half ml of 
the serum derivative was combined with the samples to be assayed for 
prothrombin, and again all the operations were carried out in an ice 
bath. The clot assay is carried out at 37°C and since the only effect 
desired in the preincubation is the conversion of prothrombin to throm­
bin all pre-warming is kept to a minimum. The sequence of addition of 
reagents to the 37° clotting assay was as follows:
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0 minus 30 seconds put dextran-imidazole on heat
0 minus 15 seconds add sample to be assayed
0 time Ca'*"*' - thromboplastin added
0 plus 7 minutes add fibrinogen solution and time
the development of the clot.
All assays were carried out in triplicate as a standard practice. Exper­
imental values have been corrected for changes which appear during incu­
bation of the control to obtain a true estimate of enzymic reactivation. 
Enzyme specific activity is expressed in units of prothrombin produced 
per minute per milligram of enzyme protein in the incubation system.
Enzyme Purification 
Livers were removed from rats immediately after decapitation 
and placed on ice. The livers were weighed and then homogenized in nine 
volumes of 0.25 M sucrose, 0,005 M MgClg, 0.05 M KCl and 0.025 M tris 
pH 7.6, A glass and teflon Potter-Elvehjem homogenizer was motor driven 
at 500 rpm, and three complete passes of the pestle in and out of the 
glass were used for complete homogenization. Particulate cell fractions 
were removed by centrifugation for one hour at 105,000 g or for two hours 
at 78,000 g in a preparative ultracentifuge. An aliquot of the super- 
nate was removed to measure protein concentration, and it was then 
dialysed against 0.01 M KHPO^ pH 6.86 and assayed for enzyme activity.
Ammonium sulfate precipitation. One volume of a 4°C saturated 
solution of (NH^)2S0^ adjusted to pH 7.0 with NH^OH was added dropwise 
with stirring to the remaining microsomal superantant. All operations 
at this point were carried out at 4°C. When ammonium sulfate addition 
was completed the solution was allowed to stand for ten minutes and then
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centrifuged for 20 minutes at 3000 g to remove the precipitate.
The supernate from this first precipitate was removed, and a 
second volume of saturated ammonium sulfate was added dropwise with stir­
ring. The precipitate formed was collected by centrifuging and dissolved 
in a minimal volume of deionized water. It was then applied to a 4 x 30 
cm column of Sephadex G-25 and the column developed with 0.01 M KHPO^” 
pH 6.86. The column effluent was monitored for ultraviolet absorption 
at 260 and 280 nyt and the conductivity was also measured. The protein 
fraction freed of ammonium sulfate was now carried on to the next step.
CM-Sephadex fractionation. The desalted 33 to 66% (NH^)2SO4 
precipitate was placed on a 4 x 40 cm column of CM-Sephadex equilibrated
with 0.01 M KHPO^ at pH 6.86 and the flow rate adjusted to 40 ml per
hour. After 200 ml of effluent had been collected the! molarity of the 
eluting buffer was increased to 0.05 M, and after a further 200 ml were 
collected a second increase was made to 0.1 M buffer. The column was 
run at this molarity until all protein was eluted. The protein peak 
emerging with the front of the 0.05 M buffer was carried on to the next 
step.
Ultrafiltration and DEAE ion exchange. The material described 
above was placed inside a Sartorius Membranfilter with a pore size <5 nyq, 
and a negative pressure of 50 cm of mercury was applied to aid filtra­
tion. The filtrate which passed through the pores of the ultrafilter 
was collected, and concentrated using a UM-3 membrane in an Aminco Dia-
flow cell. This membrane has a molecular exclusion size of approximately
300 Daltons. After this concentration step the salt content of the 
material was reduced by washing in the Diaflow cell with deionized water.
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The remaining material was placed on a 1 x 15 cm DEAE-Sepha- 
dex column equilibrated with 0.01 M KHPO^" pH 8.0 and protein eluted 
with an increasing gradient of KCl. All fractions were collected and 
assayed for enzyme activity.
Intracellular Distribution of (U) Vitamin
(U) vitamin obtained from Hoffman LaRoche had a specific
activity of 13.7jyLC per mg. Vitamin K deficient rats were given ten to 
twenty^c of the vitamin by intraperitoneal injection, and were sac­
rificed from six to twelve hours after receiving the isotope.
Livers were homogenized in 9 volumes of 0.25 M sucrose, 0.005 
M KCl and 0.025 M tris, pH 7.6. Nuclei and cell debris were removed by 
centrifuging for ten minutes at 2000 g. With all operations carried out 
at 4°C, the nuclear fraction was resuspended in the same medium and 
collected once more at 2000 g for ten minutes.
Mitochondria were pelleted by spinning the nuclear supernate 
and wash for fifteen minutes at 10,000 g and again the pellet was washed 
once,
Microsomes were collected by centrifuging the mitochondrial 
supernate for two hours at 105,000 g. Microsomal pellets were combined 
and resuspended in 0.001 M MgCl2 and 0.05 M tris pH 7.6 so that micro­
somes from one gram of liver were suspended in 3.2 ml. At this point 
the microsomal suspension was divided in half, with one half being 
treated as a wash, while the other half was made up to 0.5% in sodium 
desoxycholate. The washed microsomes and the ribosomal fraction were 
collected by spinning for 90 minutes at 105,000 g.
All the pellets were resuspended in 0.001 M MgCl2 0.05 M tris.
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pH 7.6 and protein concentrations measured by the method of Lowry et al. 
(36). Half ml aliquots of the suspensions were removed and diluted to 
1.0 ml volume with 0.2 N NaOH. After storing at 37°C for 24 hours the 
samples were quantitatively transferred to scintillation vials contain­
ing 15 ml of aqueous scintillation medium (41) and counted in a Packard 
Tri-Carb liquid scintillation counter. Efficiencies were calculated in 
individual samples by adding an external standard of known activity, and 
from this data dpm per mg protein was calculated for the different frac­
tions .
Folch Extraction 
A chloroform-methanol extraction (42) of some fractions has 
been carried out after lyophilization to measure the distribution of
activity between lipid soluble and lipid insoluble fractions. Radio­
activity in the lipid soluble material was measured in the liquid scintil­
lation counter and compared with the total radioactivity in the sample 
before extraction.
Molecular Weight Determination 
The analytical ultracentrifuge was used to study physical 
properties of the reduced prothrombin molecule.
Sedimentation coefficient. The apparent sedimentation coeffi­
cient (sgpp ) was measured at 1.0 and 0.25% protein concentration. A 
linear dependence of s on concentration was assumed in extrapolating to
a value of s-__ at zero concentration. This value was converted to stan- ®FP




1 - l / > t
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where 20 corresponds to the viscosity of water at the experimental
temperature t, relative to that at is the relative viscosity
of the solvent to that of water. P and P  are the densities of/ 20,w / t
water at 20° and the solvent at t degrees respectively, and V is the
partial specific volume of the protein.
Diffusion coefficient. A value for the apparent diffusion
coefficient, D , was obtained from the following formula app.
2
2 -jr 
2Values of the second moment (j—  were plotted against time after bound­
ary formation in a synthetic boundary cell. The slope of the plot is 
equal to 2D. The value of Dgpp was converted to standard conditions as
follows
®20,w - °app 273'Tt ^ 2 0  ^
Molecular weight is obtained from the formula 
M = RTs_______
D (1 - V )




Hepatic Intracellular Distribution of (U) Vitamin Kt
The most notable observation about the distribution of 
labelled vitamin Kĵ  in the liver intracellular regions is a complete 
randomness of binding to all sub-cellular fractions. Not only was the 
distribution quite random, it also varied widely between the liver sub- 
cellular fractions from animal to animal. The total counts recovered 
in each sub-cellular fraction (Table 2) for ten individual rats failed 
to indicate any binding preference.
The recovery of administered in the livers after sacrifice 
was also quite variable, ranging from 50% down to less than 1% of the 
dose. These differences probably reflect different rates of transport 
from the injection site and/or different rates of excretion in the bile. 
The relatively low specific activity of the vitamin K preparation assures 
that the amount of vitamin K in these livers was adequate for normal 
physiological function. At 13.7/*c/mg the animals were receiving at 
least 0.7 mg of vitamin K]̂ . This dose is almost 100 times the amount 
required to cure deficiency symptoms when given to rats of 200 gm body 
weight.
Further assurance that adequate amounts of vitamin K have 
reached the liver in the interval between injection and sacrifice comes
27
TABLE 2
TOTAL RADIOACTIVITY RECOVERED IN LIVER SUBCELLULAR FRACTIONS 
OF RATS INJECTED WITH 10/ic l^C (U) VITAMIN Kj
Subcellular Fraction Rat Number
(total dpm) 1 2 3 4 5 6 7 8 9 10
Microsomal
Supernate 5510 53100 17220 28600 7040 5160000 2540000 4050 30000 770
Nuclei and 
Cell Debris 87200 40800 30830 60000 8830 69000 1960000 10900 286000 786
Mitochondria 8080 13760 9915 16050 6750 4420000 2890000 1800 138600 89
DOC Soluble Micro­
somal Membrane 3840 47200 5000 18060 6510 1476000 1347000 920 56700 520
Ribosomes 4500 39880 3560 4000 778 105300 63000 0 3420 0
Total 109000 194700 66500 126700 29900 11230000 8800000 17680 514200 2165
ls>00
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from single stage measurements of blood prothrombin. In this series of 
experiments all the animals except one (see Table 3) had been maintained 
on the purified diet without added vitamin K, and these animals showed 
decreased prothrombin levels in comparison to rats on a normal ration.
In all nine cases the prothrombin level showed an increase after vitamin 
K injection which was indicative of physiological dose levels. The sin­
gle normal control animal also showed the random labelling pattern among 
all sub-cellular fractions. This was taken as evidence that no particu­
lar cell fraction has sufficient vitamin K bound to tie up all the sites 
available for binding the vitamin, even when the animal is on a vitamin 
K adequate diet.
General trends include a larger amount of radioactivity in the 
fractions containing most of the cell mass. The lipid content of the 
particular cell fraction has no obvious effect on the amount of vitamin 
K bound. The supernatant fraction contains as much of the total radio­
activity as the nuclear and cell debris fraction, or the lipid rich 
microsomal fraction.
Since the distribution of radioactivity within the cell corre­
sponded closely to the distribution of mass in the different fractions, 
the data have been expressed in terms of dpm per unit amount of protein 
in each of the five fractions. This has been done by dividing the per­
centage distribution of counts in each fraction by the averaged protein 
content of each fraction on a dry matter basis. A completely random 
binding to protein should give a ratio of 1.0 for this calculated value. 
In Table 4 a look at the standard deviations from the averaged percentage 
distribution of radioactivity shows that the calculated ratios do not
TABLE 3
BLOOD PROTHROMBIN LEVELS OF RATS 
RECEIVING (U) VITAMIN
Parameter Rat Number
1 2 3 4 5 6 7 8 9 10
Initial Prothrombin Level 
(Percent of Normal) 8 100 7 < 2 8 7 10 <2 5 7
Hours Elapsed Between Vitamin 
Ki (l^c) Administration 
and Sacrifice 5 11 6 6 11 10 10 3 3 4
Final Prothrombin Level 
(Percent of Normal) 100 100 100 100 100 100 100 3 28 15
Lipid Soluble Radioactivity 
in DOC Soluble Microsomal 
Membrane (% of Total) 56 59 95 98
wo
TABLE 4










1 2 3 4 5
Rat Number 





Supt. 5 27 26 23 24 46 29 23 6 35 24 t 12 22 1.1
Nuclei and 
Debris 80 21 46 47 30 1 22 62 56 36 40 t 22 56 0.7
Mitochon­
dria 7 7 15 13 23 39 33 10 27 4 18 t 11 13 1.4
Membrane 4 24 8 14 22 13 15 5 11 24 14 t 7 7 2.0
Ribosomes 4 21 5 3 2 1 1 0 1 0 4 ± 6 1 4.0
w
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differ significantly from a value of 1.0.
The generally non-polar characteristics of vitamin make it 
an illogical candidate for complex formation with cell proteins. The 
small amount of radioactivity recovered in the cell sub-fractions could 
be interpreted as a direct association with hydrophobic regions of pro­
tein, and lipoprotein components present in the sub-fractions. As vita­
min K is a natural component of the diet one is probably safe in assum­
ing some metabolic alterations of the vitamin to occur during its stay 
in the body. Water soluble metabolites of the vitamin could account for 
binding of radioactivity to proteins. There are three components which 
have some bearing on this problem, and are easily investigated. Lipid 
soluble material resembling vitamin K^, lipid soluble material with 
differing physical properties, and protein bound metabolites of vitamin 
are all easy to quantitate.
Chloroform-methanol extraction (42) of some sub-cellular frac­
tions from individual rats was used to assess the partition of recovered 
radioactivity into the three fractions mentioned above. The chloroform 
was removed under a stream of nitrogen, and the lipid residue redissolved 
in petroleum ether. After removal of an aliquot for liquid scintilla­
tion counting, the remaining material was spotted on alumina impregnated 
filter paper (Schleicher and Schuell, #288) and developed in cyclohexane- 
benzene 7:3 (v/v). Vitamin had an Rf of 0.9 in this system, and could 
be readily separated from benzo and napthoquinone compounds lacking the 
isoprenoyl side chain, or having more than one unsaturated isoprene unit 
in the side chain. These latter compounds were slightly more polar than 
vitamin K^, and move relatively slowly in this solvent system.
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Nuclear, mitochondrial, and sodium desoxycholate solubilized 
microsomal material from rats 9 and 10 were treated in the above fashion. 
A scan of the radiochromatograms shown in Figure 1 indicates that most 
of the extracted radioactivity has an Rf corresponding to vitamin 
Only in the microsomal membrane fraction is there evidence for the pres­
ence of a lipid soluble metabolite #ith an Rf corresponding to the 2- 
methyl-1,4-napthoquinone which could be structurally related to metabolic 
products of vitamin Kĵ .
The absence of any detectable vitro effect of vitamin K, 
except in whole liver perfusion studies by Suttie (43), indicates that 
some metabolite of the vitamin is probably involved in control of pro­
thrombin synthesis. Due to an ever present difficulty in overcoming the 
concept of vitamins acting in coenzyme form, the protein bound, lipid 
insoluble radioactivity has been compared to the total radioactivity in 
a few of these cell sub-fractions.
Results from microsomes of four separate rats are included in 
Table 3. Rats 2 and 6 which were given the vitamin 11 and 10 
hours respectively before sacrifice show 56% and 59% of the microsomal 
radioactivity to be in a lipid soluble form. Rat number 2 is a control 
rat with adequate dietary vitamin K, so the similarity of response is 
interesting. It should be noted that in ten hours rat 6 has completely 
returned to normal levels of blood prothrombin, so we are looking at a 
post-induction position of the label. The amount of time elapsed since 
the administration of the vitamin also suggests that any catabolic path­
ways for elimination of the vitamin will be fully active.























0.2 0.4 0.6 0.8 1.0
Rf
Figure 1. Radiochromatograms of subcellular lipid extracts. 
The solvent system is cyclohexane;benzene 7:3 and alumina impregnated 
paper was used in ascending chromatography. Chromatograms are cut in 
half inch strips and counted in a liquid scintillation counter.
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the period of most rapid prothrombin synthesis, at three and four hours 
after administration of the vitamin Kĵ . At this time the results 
show more than 95% of the radioactivity in the microsomal membrane is 
lipid soluble. These results indicate that extensive catabolism of the 
vitamin, as seen in animals 2 and 6, is not required for prothrombin syn­
thesis.
As indicated earlier, the finding of most of the microsomal, 
as well as the nuclear and mitochondrial lipid soluble radioactivity in 
a fraction of similar Rf to native vitamin suggests that this material 
may be present in considerable excess. Perhaps the excess available over 
physiological levels in accumulating in lipophylic regions of the cell 
unit it can be used or excreted.
Properties of Bovine Prothrombin
Bovine prothrombin prepared according to the method of Moore 
et al. (8) had specific activities ranging from 1500 to 3000 Iowa units 
per milligram of protein. Reasons for this variation in purity were not 
easily correlated with techniques used in the isolation procedure. It 
was possible to correlate specific activity of prothrombin preparations 
with indications of homogeneity obtained with the analytical ultracentri­
fuge. Sedimentation runs were carried out at 52,640 rpm at 25°C in a 
Spinco Model E ultracentrifuge. Prothrombin was in a solution of NaCl, 
potassium phosphate buffer, pH 6.86 at an ionic strength of 0.1 and the 
two preparations compared in Figure 2 were both at a 1% protein concen­
tration.
Preparation #1 only assayed 1100 Iowa units per milligram of 
protein, and it showed the presence of a high molecular weight contami-
(jjo\
Figure 2, Comparison of Schlieren patterns and specific activity of two 
prothrombin preparations. The upper pattern shows preparation number 1, with a 
specific activity of 1100 units per mg. Exposures are at 8 minute intervals. Lower 
pattern is preparation number 4, assaying 2900 units per mg, exposures at 4 minute 
intervals.
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nant. Preparation #4 assayed at 2900 Iowa units per milligram protein, 
and the contaminant species had almost completely disappeared. Cellulose 
acetate microelectrophoresis showed three or four bands staining for pro­
tein when preparation #1 was run for twenty minutes at 250 volts in 0.05 
M pH 6.86 phosphate buffer. A comparison between preparation #1, and a 
second preparation assaying at about 2000 units per milligram protein is 
given in Figure 3.
No free sulfhydryl groups were detectable by the DTNB assay in 
native prothrombin. An estimate of the number of disulfide bonds present 
in the native molecule has been made by incubating prothrombin in 8 M 
urea with 10“^ M 2-mercaptoethanol at pH 8.5. Following acidification, 
and removal of urea and mercaptoethanol by Sephadex 6-25 gel filtration, 
the reduced material was assayed for free SH-groups with DTNB. After 
measuring the concentration of protein and SH-groups in the same sample, 
the results were expressed as micromoles of SH-group per micromole of 
native protein (Table 5). The average of eight determinations gave a 
value of 15.3 SH-groups produced per molecule of native material, indi­
cating a minimum of 8 disulfide linkages in the native prothrombin mole­
cule.
Since the thrombin molecule is thought to have a molecular 
weight of 9000 to 12,000 Daltons, it is possible that two or more throm­
bin molecules could arise from the activation of a single prothrombin 
molecule. This could be most easily imagined if prothrombin contains 
two or more identical subunits. The structure of the reduced material 
was investigated for this reason.
Disulfide reduction in prothrombin at neutral pH without urea
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Figure 3. Electrophoretic test of homogeneity. The two 
applications on the left are material from preparation 1. Four distinct 
species are present. In preparation 3, on the right, the material 
appears to be uniformly present at one location. Electrophoresis was 
run for 20 minutes at 250 volts in pH 6.86 buffer.
39
TABLE 5
DTNB REACTIVE SULFHYDRYL GROUPS PER MOLECULE 
OF REDUCED PROTHROMBIN











was accompanied by aggregation and precipitation of the protein. For 
this reason, no attempt was made to work with the material in the ab­
sence of urea. The sedimentation characteristics of prothrombin were 
studied in a solution of 8 M urea, 10~^ M 2-mercaptoethanol, and suffi­
cient 5% aqueous methylamine to bring the pH to 8.5. The results of 
physical measurements made on this solution are given in Table 6.
Prothrombin Assay
The unusual relationship between concentration of prothrombin 
and clotting time of an assay system is commonly referred to in the lit­
erature (44, 45). Two aspects of the unusual relationship are; (1)
Lack of reliability of dilution curves run on single samples for pre­
dicting dilution curves of other samples (2) Failure of the log - log 
plot of prothrombin concentration versus clotting time in seconds to 
reveal anything meaningful about the reaction being studied. The avail­
ability of purified prothrombin for study under conditions normally used 
for whole plasma was considered too great an opportunity to pass up.
Prothrombin assays referred to in the following section of 
this chapter have been performed on several different preparations of 
bovine prothrombin, of differing degrees of purity. The necessity for 
converting prothrombin times into units of prothrombin preparations be 
compared. Three preparations were compared for their behavior on dilu­
tion. Specific activities for the three preparations were 2500, 1600, 
and 1900 Iowa units per milligram of protein, for preparations 5, 9, 
and 6 respectively. If the impurities in preparations 9 and 6 represent 
substances which are inhibitory in the clotting assay, then dilution of 
these samples might have a different effect on clotting activity than
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TABLE 6
MEASUREMENT OF PHYSICAL PARAMETERS OF 
REDUCED PROTHROMBIN SOLUTION
Parameter Experimental Value
p  (gm/cc at 20°C) 1.1462
’?? ??tJ 7)20L t 4 1.5069
V  (ml/gm) 0.714






D (cm / sec) 7.812 X 10
M (Daltons) 48,052
(a) Value obtained by extrapolation to zero concentration.
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diluting the purer preparation, number 5. Figure 4 shows a dilution 
curve prepared from averages of the three separate curves, with standard 
deviations from the average line being indicated at each point of meas­
urement. The good fit of the data to one curve indicates the absence of 
inhibitors of the clotting reaction in protein contaminants in prepara­
tions 9 and 6.
These results raise the possibility that variations in dilution 
curves occurring between different plasma samples could result from dif­
ferent levels of activator or inhibitor substances present in plasma, 
but removed during the purification procedure. The averaged curve pre­
pared from the three samples was then used as a standard curve for relat­
ing clotting time to prothrombin concentration in units. The increased 
scale drawing of the curve used in the assays in section four of this 
chapter is shown in Figure 5. Clotting time changes occurring during 
experimental procedures can be readily converted to units of prothrombin 
activity by using this graph.
Nothing has yet been said of the usefulness of this type of 
graph in determining chemical events occurring during the clotting pro­
cess. Neither this linear plot of time versus prothrombin activity, nor 
Hemker's rectilinear log - log plot are very useful in predicting the 
type of reaction which is being observed. Since the value of kinetic 
data lies with its ability to give comparisons between model reaction 
schemes and individual situations under study it was considered useful 
to express the data in a more conventional form. The usual way of com­
paring enzyme concentration to activity involves plotting enzyme concen­







PROTHROMBIN CONCENTRATION (units/ 0.1 ml)
Figure 4. Comparison of clotting time with prothrombin concentration in purified prepara­







Figure 5. Prothrombin assay curve. The difference in clot­
ting time between two samples is converted into units by referring to 
this graph.
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a fixed substrate concentration.
As the two-stage assay is used it can only measure one level 
of product, i.e. the critical fibrin concentration required to trigger 
the polymerization reaction. However, it is still possible to think of 
amount of product formed per unit time. This can be done by considering 
the critical fibrin concentration as a unit amount of product. Then for 
a ten second clotting time one-tenth of the unit amount is produced per 
second, for a 100 second clotting time, one-hundredth of the unit amount 
is produced per second. Thus a plot of the reciprocal of clotting time 
versus prothrombin concentration should give results which are comparable 
to standard systems if the rate of fibrin production is linearly related 
to prothrombin concentration. This type of plot is given for dilutions 
of preparations 9 and 6 in Figure 6. This method of presentation can be 
supported mathematically, and the type of curve to be expected in a nor­
mal system is predicted by a look at Michaelis treatment of this situa­
tion. The standard form of Michaelis kinetics applicable here is
V = _dS_ = kEpS (1)
" dt 1 + Kg
Where the term - dS/dt refers to substrate disappearance per unit time, 
k is an empirical reaction constant, Eq represents total concentration 
of enzyme present in the system, S refers to concentration of substrate 
in the system and Kg is the equilibrium constant of the dissociation of 
ES into free enzyme and substrate.
If we integrate the differential form of the equation between 
the limits of the initial substrate concentration and the final con­










Figure 6. Plot of enzyme activity against concentration. The 
extrapolated initial rate is obtained by increasing the scale of the graph. 
Prothrombin preparations 6 A and 9 0  are compared here.
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_  _É1 _ (1 + Kg) = k Eo / dt (2)
Srt
Ihen Integration gives
(1 + Kg) (In So - In S) = k Eq (t - o) (3)
and rearranging this equation for convenience shows that 
(1 + Kg) (In So/S) ^ g
k t
Now we know that for the assay conditions used the term In 
Sq/S should always be constant. This is based on the assumption that a 
constant amount of fibrinogen must be converted to fibrin to initiate 
the polymerization reaction actually serving as endpoint of the assay. 
Standardization of reagents for the assay provide a constant level of 
substrate in all situations. The we can let the constant terms from 
equation (4) be represented by 1/K*, and the equation reduces to
_1_ = Eo K* (5)
t
Equation (5) is the description of a straight line having a slope of K* 
and an intercept of zero when the reciprocal of clotting time is plotted 
against enzyme concentration.
A comparison between the predicted model and Figure 6 reveals 
that the data only fit the proposed model for very low enzyme concentra­
tions. Curvilinearity appearing at higher enzyme concentrations is begin­
ning to have an effect even at physiological levels of prothrombin con­
centration. For this reason it is interesting to propose models for 
explaining the data, and to test such models by comparison with kinetic 
parameters derived from this system.
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The most obvious initial model which comes to mind is end- 
product inhibition of the thrombin mediated conversion of fibrinogen to 
fibrin by either fibrin or the fibrinopeptides. This model is based on 
the assumption that the initial rate of conversion of fibrinogen to fib­
rin is being measured only in the case of low prothrombin concentrations. 
Even if an initial linear rate of fibrin formation occurs at high pro­
thrombin concentration, the requirement of the assay for a fixed fibrin 
concentration needed to initiate polymerization could be masking this 
initial rate by requiring the reaction to proceed to a point where pro­
duct inhibition is important. A graphic portrayal of this idea is given 
in Figure 7.
The simplest kinetic treatment of this situation assumes sim­
ple competitive inhibition by product. The Michaelis expression for 
this situation is:
dS = __________ k Eq__________
dt T ^ (6)
where I represents inhibitor concentration and is the dissociation 
constant of inhibitor enzyme complex. Setting up for integration we 
have:
|S • 4 ^  • ^  dS = kE„ if dt (7)
The term - (1 + Kg/S) from equation (7) will not vary under the assay 
conditions so is set equal to K*. Since the inhibitor in this system 
is hypothesized to be product, the value I can be expressed in terms of 









Figure 7. Hypothetical relationship between enzyme concen­
tration and product inhibition. Assuming Fg to be the critical fibrin 
concentration required to initiate polymerization, then at high enzyme 
concentrations (E)^ and (E)/̂  the rate of fibrin production could be
decreased before Fg is reached.
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then
I = Sq - S (8)
Substituting equation (8) into (7) and rearranging gives:
''S /t
K' K g S ^  _ K' y  dS = k Eo j dt (9)
and integration yields:
Sq (s - ŝ ) - K* Ks In So = k t (10)
Ki Ki S
Again the absence of any variable entities in the left hand side of the 
equation under the conditions of the assay allow setting it equal to a 
constant K* '. Now we see the familiar form:
1 = _k  Eq or _1_ . K'»' Eo (11)
t K "  t
This plot is obviously linear in nature, and does not fit the 
observed data. It appears that the peculiar conditions imposed by 
assaying to a fixed product concentration would mask effects of any com­
petitive product inhibition. Thus the curvilinear nature of the enzyme 
activity versus concentration plot is not due to competitive product 
inhibition.
Another possible source of inhibitor in the clotting assay is
the remaining portion of the prothrombin molecule which is not converted
to thrombin. Bovine prothrombin is approximately six times as large as
bovine thrombin on the basis of molecular weight. If an inhibitor of 
thrombin activity can arise during the activation of prothrombin the 
following situation should hold:
Z  ». E + I El (12)
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where Z represents prothrombin, E represents thrombin, and I the hypo­
thetical inhibitor. Then the total amount of enzyme produced on pro­
thrombin activation, Eq , is equal to the amount of inhibitor, I produced. 
The concentration of enzyme actually assayed is (E) since
(E) = (Eg) - (El) (13)
The concentration of the El complex is dependent upon its association 
constant Kg by the following definition:
(El) = Kg (E) (I) - Kg (E)2 (14)
Now substituting equation (14) into (13) shows that
(Eq ) = (E) + Kg (E)2 (15)
From this relationship it is apparent that at low levels of Eq , (Eq )
should approximate (E), and for high concentrations of Eq , (Eq ) will 
2approach (E) Kg. This observation predicts that a linear plot should 
be obtained by plotting enzyme activity against the square root of en­
zyme concentration at high enzyme concentrations.
Figure 8 shows that such a linear region is obtained if the 
general type of data presented in Figure 6 is plotted as the square root 
of enzyme concentration. Thus the data do fit the hypothesis of an in­
hibitor being produced from prothrombin as it is activated to thrombin.
The data available allow a calculation of the numerical value 
of the association constant of the enzyme-inhibitor complex. Such a 
calculation is based on the assumption that the linear region of the 
plot of enzyme activity versus concentration which is observed at very 
low enzyme concentration represents the situation where the inhibitor 
concentration has not become high enough to affect reaction rate. Ex­
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Figure 8. Plot of enzyme activity against the square root of 
enzyme concentration. Enzyme used for this experiment was prothrombin 
preparation number 6.
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plot of activity against (E), while the actual curve represents (Eq ) 
values (see Figure 6). From Figure 6 it is possible to correlate the 
assumed value of (E) with the known value (E^) at any given level of 
enzyme activity. A value for can then be obtained by substituting 
into equation (15). Empirical values for Kg calculated in this manner 
range from 140 to 160 liters grams
It is also possible to obtain an estimate of Ka from the rela­
tionships of the linear slopes of Figures 6 and 8. From (15) at high 
enzyme concentration the relationship
(E) = Æ Ô  (16)
holds true. The slope of the line in Figure 6 is given as K* in equa­
tion (5) where it was assumed that (Eq) was equal to (E). Substituting 
equation (16) into equation (5) gives:
-1_ » K* JÔM (17)
where the slope of the line in Figure 8 is now represented by the term 
K* / No w  it is apparent that the slopes of the two lines are 
related and
slope (Figure 6) - ^ ______  = JÊT" (18)
slope (Figure 8) R* /
so Kg can be calculated from the following:
2Ka - f slope (Figure 6)] 
^ slope (Figure 8)J
(19)
The value for Kg calculated from this equation is 225 liters grams ~1. 
Thus the estimations of dissociation of the enzyme-inhibitor complex, 
El, give a Kĵ  value of 0.85 x 10"^ M.
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Prothrombin Reactivation 
Simple proteins containing few disulfide bonds are known to 
be capable of regaining native characteristics after disulfide reduction 
(46). Appropriate conditions for slow reoxidation of sulfhydryl groups 
lead to some recovery of activity. This reactivation can occur most 
rapidly in the presence of a microsomal enzyme containing a free sulf­
hydryl group in the native form, and acting as a catalyst for disulfide 
exchange reactions.
This particular enzyme has no specificity for the type of pro­
tein molecule which is to be renatured. Since it is non-specific, the 
enzyme may be thought of as a free sulfhydryl donor, a sort of giant GSH 
molecule attached to the microsomal membrane. Unique properties of this 
enzyme must lie in the amino acid sequence around the reactive half cys­
tine residue involved in disulfide interchange reactions (47).
Characterization of this type of activity does not seem to 
lead us any closer to an answer to the problem of assembling complex 
proteins containing inter as well as intra-molecular disulfide bonds. 
Although primary structure of proteins can dictate thermodynamic condi­
tions which affect secondary, quaternary, and tertiary structure the 
existence of alternate mechanisms for specifying correct configuration 
cannot be completely ruled out. Moreover it becomes a weighty problem 
if one has to consider the logistics of correct pairing of half cystine 
residues in a protein containing more than five or six disulfide bonds.
Bovine prothrombin preparations reduced for 12 hours at 24°C 
in 8 M urea solution with 10"^ M 2-mercaptoethanol at pH 8.5 show no 
clotting activity after removal of denaturing agents. Since philosophi-
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cal considerations require that the reduced form of the protein, or some 
mixed disulfide thereof be an intermediate between free amino acids and 
the active enzyme, the cell must be able to match sulfhydryl groups 
properly and oxidize them to give a configuration with enzyme activity.
A search has been conducted for this type of activity in rat liver sub- 
cellular preparations.
A rational consideration of this type of activity suggests 
that it must reside at a location within the cell close to the protein 
synthesizing apparatus. Unfortunately microsomes are known to contain 
prothrombin activity which is released under appropriate incubation 
conditions. Thus a search for the type of activity of interest would 
be complicated by the problem of distinguishing between release of nas­
cent prothrombin, and reactivation of reduced prothrombin in microsomes. 
For this reason reactivation activity has been investigated only in the 
microsomal supernate fraction.
Initial problems with the two-stage assay procedure indicated 
that potassium phosphate and tris buffers are both unsuitable for reac­
tivation. Both these buffers cause problems in the assay technique.
For simplicity a buffer was chosen for reactivation studies which would 
not interfere with subsequent assay techniques - Krebs-Ringer was the 
logical choice.
Results of the initial trial performed with Krebs-Ringer buffer 
are given in Table 7. The results given here are measurements of the 
clotting time of aliquots removed from the combination of 0.5 ml of 
incubation mixture and 0.5 ml of a 1:20 dilution of the bovine serum 
preparation in physiological saline. Incubation was carried out for 30
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TABLE 7












+ + + 130
+ + + 210
+ + + + 194
+ + 195
+ + + 192
+ + + 185
+ + + + 155
Incubation system consisted of 2.0 ml Krebs-Ringer buffer, pH 
7.0, and 0.1 ml of reduced prothrombin (0.05 mg protein) in 0.1 M acetic
acid for a final volume of 2.10 ml. GSH and DHA were dissolved in the
incubation buffer. When rat liver enzyme was added, it replaced an 
equivalent volume of Krebs-Ringer buffer, so a constant incubation vol­
ume was maintained. Incubation was carried out at 37° for 30 minutes.
(a) GSH and DHA present at a final concentration of 1 x 10'^ M.
(b) microsomal supernate added as 0.5 mg of protein.
(c) microsomal disulfide interchange system added as 0.1 mg protein.
(d) see methods section for description of clotting assay.
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minutes at 37°C in a shaking waterbath. Reduced glutathione (GSH) and 
dehydroascorbate were added to give a final concentration of 10"^ M. 
Activity in microsomal supernatant protein was investigated by adding 
0.5 mg of dialysed microsomal supernatant protein prepared from rat liver. 
Microsomal disulfide exchange system was compared at the stage of purity 
obtained with ammonium sulfate fractionation of a microsomal acetone 
powder. One tenth of a milligram of protein was added, and this amount 
gives good reactivation of reduced bovine pancreatic ribonuclease (46).
The denatured prothrombin used as substrate in this assay con­
tained 5 0 moles of free sulfhydryl group (SH) as measured by the DTNB 
reaction per^mole prothrombin. Although it was not realized at the 
time this represents a considerable contamination of the sample with 
2-mercaptoethanol. This may have a bearing on dehydroascorbate (DHA) 
requirement which appears uniquely in this experiment. This experiment 
was designed to test the ability of crude microsomal supernatant protein 
as compared with partially purified microsomal disulfide interchange 
enzyme in producing prothrombin activity.
The incubation systems containing dialysed crude microsomal 
supernatant show considerably more prothrombin activity than those with 
microsomal disulfide interchange system. No clear cofactor effects are 
observed here, although it is perhaps significant that controls lacking 
enzyme source, but containing GSH or DHA did not vary greatly from the 
control with no additions.
Rough testing indicated that most of the microsomal supernat­
ant enzyme activity was present in protein precipitate from 33 to 66% 
saturation with (NH^)2S0^. This preliminary evidence was verified in
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the experiment presented in Table 8. Since the previous experiment 
showed the largest amount of prothrombin activity in the system contain­
ing dialysed crude microsomal supernatant and DHA, the effect of DHA 
was checked with the fractions of microsomal supernatant used this time. 
Ammonium sulfate fractionation of microsomal supernatant was carried out 
as described in the methods section, and desalted on Sephadex G-25.
Again 0.5 mg of enzyme protein was added per incubation except for 0.1 
mg of microsomal disulfide interchange preparation. Fresh substrate 
used in this assay showed a value of 18 moles SH per mole of prothrombin, 
and this value has subsequently proved much closer to an average than 
50 moles SH per mole.
Without the excess SH present in substrate, DHA has no appar­
ent effect on production of prothrombin activity. Microsomal disulfide 
interchange enzyme either alone, or in combination with other enzyme 
fractions shows no effect on the system. The largest amount of prothrom­
bin activity appeared in the tubes containing the 33 to 66% ammonium 
sulfate cut of the microsomal supernatant. Again there was no effect 
of microsomal disulfide interchange enzyme, and heating the enzyme 
fraction for 2 minutes at 60°C prior to assay produced a marked reduc­
tion in activity. Due to an oversight the crude microsomal supernatant 
fraction was not dialysed before the assay, and failure to dialyse blocks 
all activity.
At this stage several questions arose as to the nature of the 
"prothrombin activity" appearing during the incubation of reduced pro­
thrombin. Two of the major ones were: (1) is prothrombin activity
appearing in the control tube during incubation? and (2) do all the
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TABLE 8
ACTIVATING FACTOR (AF) ACTIVITY IN AMMONIUM SULFATE 
FRACTIONS OF MICROSOMAL SUPERNATE
Additions®
(NH^)2S0^ Fraction of Microsomal Supt. 





+ + 125 t 3.7
+ + + 120 t 3.7
+ + + 102 - 3.3
+ + + 85 t 4.2
+ + + 107 t 0.8
+ 87 t 2.6
+ + 115 t 1.7
^System as described in Table 7. Enzyme was present as 0.5 
mg protein where added.
^Enzyme fraction heated at 6QOC for two minutes prior to 
addition to incubation tube.
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incubation mixtures start out at zero time with the same amount of activ­
ity?
The first question is important in understanding whether enzyme 
is an absolute requirement for obtaining prothrombin activity in the incu­
bation system. As the assay is being run presently there is no informa­
tion available as to the effect of incubation in an air atmosphere at 
pH 7,0 upon production of prothrombin activity. These conditions result 
in rapid oxidation of half cystine residues to the sulfonic acid deriva­
tives in the presence of heavy metal ions. Some disulfide formation may 
also be occurring. Is any of this oxidation restoring activity to the 
reduced material?
The second question is essentially asking if any prothrombin 
activity is being added with the enzyme protein. All other components 
of control and experimental system are identical. Results obtained so 
far are only valid if there is no prothrombin activity in the enzyme
preparation. This has been assumed, since observations on the intra­
cellular localization of prothrombin activity in subcellular liver prep­
arations have shown the level of prothrombin to be below the threshold 
for detection in the soluble protein fraction.
In order to check on these two points all subsequent assays
have been performed with non-incubated zero time controls for comparison 
with incubated values. All components were added to the incubation tubes 
while they were kept in an ice bath. When the total incubation volume 
of 2.10 ml is reached, 0.5 ml was withdrawn before incubation and added 
to the serum source of Factors V and VII. Zero time values were assayed 
while the remainder of the material was being incubated. When the pres­
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cribed Incubation period had been completed, the tubes were removed from 
the water bath, placed in an ice bath, and a second aliquot of 0.5 ml 
removed for analysis.
Initial results from this controlled form of the assay are 
presented in Table 9. It is apparent that the zero time values do not 
vary greatly among themselves. This observation has held up quite well 
over many assays, and the apparent uniformity of this value is taken as 
evidence that the enzyme fractions being added do not contain prothrom­
bin activity. Variations which do occur are attributed to difficulty in 
reproducing the transfer of small volumes exactly.
This initial trial does show some activity developing in the 
control tube. Again this type of experiment has been repeated many 
times, and this observation has not been consistent or reproducible.
There is no reason to suppose that air reoxidation of prothrombin cannot 
lead to some restoration of correct disulfide pairing and enzyme activity. 
The amount of such non-enzymic reactivation would be expected to show a 
dependence on the purity of the prothrombin preparation. Enzymic react­
ivation which must operate in vivo in an environment containing many 
heterologous protein species could show a lesser dependence on purity of 
substrate. The purity of the prothrombin preparations has varied slightly 
with no effect on ability to observe enzymic reactivation of reduced 
material. Therefore, the changes occurring in the non-enzymic control 
are routinely subtracted from gross activity in the experimental tubes 
to obtain a net enzymic reactivation.
The astute reader will note substitution of the term "react­
ivation" (renaturation) for the more general "appearance of prothrombin
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TABLE 9
AF ACTIVITY IN CM-SEPHADEX FRACTIONS OF A 33-66% (NH^)«SO^ 











None 156 147 9 0 4.8
Microsomal
Supernate 158 148 8 0 7.9
33-66%
(NH4)2S04 160 142 18 9a 0.0
CM-Sephadex 
Peak 1 158 135 23 14a 1.5
CM-Sephadex 
Peak la 156 131 25 16® 3.1
CM-Sephadex 
Peak 2 155 139 16 7® 3.6
CM-Sephadex 
Peak 3 162 165 -3 0 3.3
Significant enzyme activity at the 0.05 level of probability. 
Enzyme incubation system as in Table 7.
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activity". It is felt that some justification has been provided for 
this semantic switch. If a temporary suspension of disbelief can be 
maintained further evidence to support this change is forthcoming.
Additional information about the system requires further puri­
fication of the enzyme. The results of initial purification procedures 
following the 33 to 66% ammonium sulfate cut were given in Table 9.
From 200 to 400 mg of dialysed 33 to 66% ammonium sulfate cut 
of the crude microsomal supernatant were placed on a 4 x 40 cm. column 
of carboxy-methyl Sephadex (CM-Sephadex) equilibrated with 0.01 M KHPO^” 
pH 6.86 and maintained at 4°C. The column was developed by increasing 
the molarity of the eluting buffer. A typical elution pattern obtained 
by diverting the column effluent through a Beckman model 135 Spectro- 
monitor, is presented in Figure 9. With a flow rate of 50 ml per hour 
the column performed best with about 300 ml volumes of each ionic 
strength of buffer in a stepwise gradient. The first peak to emerge, 
representing overload and unretained material, and coming off in 0.01 M 
buffer was called peak 1. Subsequently peaks 2 and 3 were eluted, with 
most of the protein emerging with the front of increasing conductivity. 
Materials eluted with 0.05 and 0.10 M buffer were called peaks 2 and 3 
respectively. Since this material obviously did not represent any degree 
of homogeneity no attempt was made to check activity in individual frac­
tions collected within a peak. Rather the entire material was combined 
and assayed. Results in the previous table show the greatest specific 
activity to be present in a peak which appears to be an adjunct of peak 
2, which in this case emerged prematurely and was unfortunately called 









Figure 9. Protein elution pattern off CM-Sephadex. This is a typical example of the 
relationship between the conductivity of the eluting buffer, and the relative amounts of 280 
absorbing material eluted from a 33-66% ammonium sulfate cut of rat liver microsomal supernatant.
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not dialysed, and shows no activity. Peak 3 appears to be slightly in­
hibitory in the clotting assay. Two tenths of a milligram of protein 
from the enzyme preparations was present in each tube.
One of the practical problems associated with column separa­
tion techniques, whether ion exchange or gel filtration is the dilution 
of sample which occurs during separation. The eluent collected off the 
CM-Sephadex column presented this problem of containing a small amount 
of protein in a large volume. Since concentration by lyophilization has 
the double disadvantage of possible loss of enzyme activity, as well as 
concentration of salt along with the protein, an ultrafiltration tech­
nique was attempted. The particular apparatus used consisted of a thick- 
walled collodion bag (Sartorius Membranfilter) with an opening for sample 
insertion and atmospheric equilibration, and a surrounding enclosed cham­
ber. The chamber is evacuated to a pressure of 10 cm of mercury, and 
the pressure differential aids flow of liquid and small molecules through 
the pores in the collodion. Manufacturer's specifications give a pore 
diameter of <5 m^ . Although a defined pore size cannot specify exact 
pore exclusion size in terms of molecular weight, an approximate value 
for a 5 mjx pore would be a protein of 20,000 Daltons. With pore size 
<5 tajA one would expect a corresponding reduction in exclusion size.
In this fashion it was hoped to concentrate the activity suf­
ficiently to attempt another purification step in a rapid manner which 
would not concentrate the buffering salts. Table 10 shows the unexpected 
results which were obtained on assaying the resulting materials. The 
activity present in peak 2 came through the ultrafilter membrane. Since 













Control (Expt 1) 234 212 22 0 22.8
Ultrafiltrate 
CM-Sephadex 
Peak 1, 4.0% 220 211 9 17.5
Non-filterable 
CM-Sephadex 
Peak 2, 125% 210 197 13 15.0
Ultrafiltrate 
CM-Sephadex 
Peak 2, 2.0% 217 192 25 3 7.3
Non-filterable 
CM-Sephadex 
Peak 3, 125% 186 191 -5 5.7
Ultrafiltrate 
CM-Sephadex 
Peak 3, 3.0% 172 174 -2 4.2
Control (Expt 2) 148 146 2 0 6.2
33-66% (NH.). 
SO4, 200 % 154 131 23 21® 6.3
Mon-filterable 
CM-Sephadex 
Peak 1, 100% 143 138 5 3 9.6
Ultrafiltrate 
CM-Sephadex 
Peak 2, 1.0% 147 129 18 16® 6.1
Enzyme incubation system as in Table 7. Significant enzyme 
activity at the 0.05 level of probability.
supernate.
Treatment of a 33-66% (NH^)2S0^ cut of rat liver microsomal
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behind in desalting the ammonium sulfate cut on Sephadex G-25, the mater­
ial coming through the filter only represents a small range of molecular 
size. Most of the protein was retained in the filter, and a good puri­
fication was obtained.
Some of the difficulties encountered with the assay technique 
are also revealed in this table. In the first part of the assay consid­
erable variation occurred in results from the first control. This vari­
ation was almost large enough to mask enzymic effects occurring in the 
experimental tubes. Due to such problems, mean standard errors have 
been computed from standard deviations of the three zero time and incu­
bated values. Differences between the two means must exceed twice the 
standard error of the means for statistical significance at the 0.05 
level. This explains the presence of the doubled error mean square value 
in the tables.
At this point in history two sources of doubt about the val­
idity of the assay technique were particularly worrisome.
Firstly, what is the source of the zero time, non-incubated 
prothrombin activity in the incubation system? Do these values repre­
sent residual prothrombin activity remaining after disulfide reduction?
The answer to this question is a very definite no. Two separ­
ate lines of experimental evidence supporting this negative conclusion 
are cited here. In the first place it is known that the bovine serum 
preparation used as a source of Factors V and VII contains residual 
prothrombin activity. The amount of this activity, and clear evidence 
of its origin, can be demonstrated easily with a different kind of con­
trol - one lacking reduced prothrombin. In this manner the knowledge
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of an origin for this prothrombin activity, and the ability to quantitate 
it readily, can be used to provide definite evidence that no activity is 
present in the reduced prothrombin.
Table 11 shows results of an experiment designed to answer 
this question. It also answers the second major problem alluded to above. 
The uniformity of values obtained from the zero time assays has been 
taken as proof that no prothrombin activity is added to the incubation 
mixture with the enzyme. However, prothrombin activity could be produced 
from the AF enzyme during incubation.
Such a possibility has already been rendered unlikely by the 
estimate available for the approximate size of the molecule exhibiting 
AF activity. Bovine prothrombin is reported to have a molecular weight 
of 68,000, and the usual ideas of zymogen - active enzyme relationships 
make it difficult to conceive of a precursor molecule smaller than its 
native active form. As shown in Table 11 there is no appearance of pro­
thrombin activity in incubation mixtures containing AF unless reduced 
prothrombin is also present.
Another important point is the effect of the AF preparation 
on activity of normal native prothrombin. This was investigated using 
purified prothrombin from bovine preparation number three corresponding 
to 0.05 units of prothrombin. AF activity was supplied in the form of 
400 y of protein from CM-Sephadex peak 2 level of purification. Table 
12 shows that no significant differences in prothrombin activity appear 
between tubes incubated with and without enzyme. Native prothrombin 
does not seem to be affected by incubation with the AF enzyme.
The preceding results have been considered ample justification
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TABLE 11
EFFECT OF TWO DIFFERENT FACTOR V AND VII PREPARATIONS 
ON THE POST-INCUBATION ASSAY
Additions Prothrombin Time (Seconds)
AF® Reduced
Prothrombin
Factor V & VII 





+ + 72 69 3
+ + 108 104 4
+ + + 72 59 13
+ + + 110 93 17
Source of AF enzyme in this experiment is 100 Jf of 33-66% 
ammonium sulfate precipitated microsomal supernatant protein from rat 
liver. Enzyme incubation system as in Table 7.
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for the use of the term “'reactivation'’ in describing the experimental 
observation, and calling the enzymic activity "Activating Factor".
A time curve of the reactivation process carried out with l.OJ 
of AF protein at the level of purity obtained after ultrafiltration is 
shown in Figure 10. On the basis of this information, and an earlier 
time curve run with ammonium sulfate-precipitated protein, a fifteen 
minute incubation period has been used routinely. These data have now 
been converted from seconds of reactivation into units of prothrombin 
produced during the incubation. This conversion was essential since 
there is no absolute relationship between change in clotting time and 
units. The conversion has been made using values obtained by diluting 
two separate prothrombin preparations and plotting units of prothrombin 
versus clotting time (see section in this chapter dealing with assay 
methods).
One unit of AF activity is then defined as the activity re­
quired to renature one unit of prothrombin in one minute. Specific 
activity is then units of prothrombin renatured per minute per milligram 
of enzyme protein. Using these definitions, a purification table is 
presented (Table 13).
In this particular purification the starting material was 
liver from eight adult male rats averaging 250 gm body weight. Total 
wet liver weight was 65 gm. Enzyme activity in each fraction was esti­
mated by using three different enzyme concentrations and a single, fif­
teen minute incubation period. Specific activities given in the table 
are taken from enzyme levels insufficient to consume all the substrate 
in the fifteen minute incubation time.
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TABLE 12











None 88 87 1 0 2.7
CM-Sephadex 
Peak 2, 200J 85 83 2 1 3.4
^Enzyme incubation system as in Table 7 except that instead of 
reduced prothrombin, the native protein has been used as substrate in 




Total Activity Yield Specific Activity 
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MINUTES OF REACTIVATION INCUBATION
Figure 10. Effect of incubation time at 37 on amount of pro­
thrombin activity produced. In this experiment, reduced prothrombin was 
present at a concentration of 45 y per ml and enzyme purified to the level 
of S&S ultrafiltrate was used at a concentration of 0.5 y per ml in the 
reactivation system. Values represent differences between control tubes 
lacking enzyme, and simultaneously incubated tubes containing enzyme.
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It should be noted that low yield at the ammonium sulfate pre­
cipitation step is mainly a result of mechanical difficulties. Using 
G-25 Sephadex for desalting large amounts of protein with a fixed column 
size leads to overlapping between the protein and salt peaks. Monitoring 
of the column effluent for conductivity can be used to discontinue col­
lection before appreciable ammonium sulfate has come through. Thus the 
overlapping protein is sacrificed. Incidentally, the emergence of AF 
activity in the G-25 void volume at this step is taken as evidence of a 
molecular weight greater than 5000.
At the level of purity reached after ultrafiltration the ultra­
filtrate has occasionally been concentrated by lyophilisation. When 
lyophilisation is used instead of ultrafiltration with a membrane of an 
exclusion sise of less than 1000 molecular weight, then a good part of 
the dry product obtained is buffering salt. On one occasion the salt 
accumulated during lyophilisation was removed by another passage through 
G-25 Sephadex. It was of considerable interest to observe two separate 
peaks of ultraviolet absorbing material in the column effluent. The peak 
emerging from the void volume had a specific activity of 1.2 AF units 
per milligram protein. The smaller peak representing retained protein 
had a specific activity of only 0.067 AF units per milligram of protein.
No mention has been made yet of the amount of reduced prothrom­
bin protein added as substrate in the incubation system. Exact control 
of amount of substrate between different experiments is not required, 
since meaningful comparisons are made on data within, not between experi­
ments. Protein concentration in the different prothrombin preparations 
varies from 6 to 15 mg per milliliter. The concentration is diluted on
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addition of urea, 2-mercaptoethanol and methylamine. Gel filtration 
techniques used for removal of reducing agents further dilutes the pro­
tein concentration down to a region of 1 mg per ml.
How much of the original activity is represented by activity
produced during enzymatic reactivation? A wide range of substrate con­
centrations has been investigated, and the amount of reactivation ob­
tained remains constant until substrate becomes the limiting factor.
The theoretical yield of activity is only 0.5% at a concentration of 
20.8 % per ml of reoxidation system. As the substrate concentration is 
lowered to 6.0 ̂  per ml theoretical recovery is 1.2% and at 1.25 j per 
ml recovery has increased to 4.2% of the activity added. When the sub­
strate concentration is at 0.6 y per ml the largest percentage of reacti­
vation is obtained. At 0.1 micro grams per ml the limits of the assay 
system have been reached, and no reactivation can be measured.
The maximum recovery of added activity observed to date with 
the standard reactivation system is 12% when substrate is present at 
0.5 micrograms per ml. A summary of results obtained from experiments 
in this area is presented in Table 14.
At this stage it is pertinent to ask about the type of function
such an enzyme could have in vivo. This problem was attacked by investi­
gating enzyme levels in vitamin K deficient rats. If any changes in the 
level of AF activity can be observed in vitamin K deficiency then we have 
presumptive evidence for the involvement of this enzyme in _in vivo pro­
thrombin synthesis.
Initial investigations were made by pooling livers of several 
vitamin K-deficient rats. Two separate pools were made of four rat livers
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TABLE 14
EFFECT OF SUBSTRATE CONCENTRATION ON THEORETICAL YIELD 
















Enzyme incubation system as in Table 7, except the concentra­
tion of substrate has been varied.
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each. Microsomal supernate was prepared in standard fashion, and AF 
activity was assayed at the 33 to 66% saturated ammonium sulfate-precip- 
itable fraction level of purification. Fifty micrograms of enzyme pro­
tein was used per assay, and normal rats were used as a source of control 
enzyme. The first group of four had whole blood single stage prothrombin 
times of 27, 41, 71 and 24 seconds, for an average prothrombin level of 
20% of normal. The second group of four had clotting times of 30, 78,
33 and 53 seconds and averaged 14% of normal prothrombin level. Table 
15 gives the results of an assay comparing these two enzyme preparations 
with enzyme from normal animals. Mo statistical significance appears 
between the amount of reactivation produced in the normal preparation as 
compared with the preparation from vitamin K deficient animals. A trend 
was observed toward lower activity in enzyme from the group of rats hav­
ing 14% of normal prothrombin levels as compared with the group having 
20%.
Five more rats were investigated, but this time the 33 to 66% 
ammonium sulfate cut of the crude microsomal supernatant was prepared 
and assayed for activity independently for each rat. This group of rats 
was allowed to become more severely depleted of vitamin K than the pre­
vious group. Results from activity assays of this group of enzyme prep­
arations shows statistically significant depression of activity in all 
five preparations as compared to the normal. Activity present in the AF 
preparations from the deficient animals ranged from zero to thirty-six 
percent of normal control enzyme. Thus it seems that a severe vitamin 
K deficiency is required to completely eliminate AF activity.
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TABLE 15
CORRELATION OF IN VIVO PROTHROMBIN LEVEL WITH 
IN VITRO AF ACTIVITY IN VITAMIN 
K DEFICIENT RATS
AF Activity
















Enzyme incubation system as in Table 7.
CHAPTER IV
DISCUSSION
Kinetic analyses has limitations, but a different kinetic 
approach to familiar data can give unexpected results. No attempts are 
being made to attack the utility of accepted methods of plotting clotting 
time in seconds against prothrombin concentration in units. This method 
is as good as any available for the estimation of unknown concentrations 
of prothrombin.
The disadvantages of this type of plot become apparent if any 
attempts are made to understand a sequence of enzymic events which occur 
during clot formation. When information about the relationship between 
enzyme concentration and rate of enzyme action is desired, it is provided 
best in this situation by plotting 1/t (seconds) against enzyme concen­
tration. Justification for this approach is provided through manipula­
tions of the Michaelis rate equation. When data obtained with dilutions 
of either citrated plasma or purified prothrombin are plotted against 
physiological ranges of enzyme concentration, the line obtained approx­
imates linearity. A slight departure from the linear condition is con­
sistently observed in the higher concentration ranges idiich approximate 
normal plasma prothrombin levels.
The assay conditions which seem to measure initial enzyme 
activity at low prothrombin concentration begin to give decreasing
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increments of enzyme activity with unit increases in enzyme concentration. 
This situation becomes more pronounced as prothrombin concentration is 
raised to 2 and 3 times normal physiological concentrations. In the 
type of plot shown it is possible to propose the presence of an inhib­
itor of the clotting reaction.
If this hypothetical inhibitor were assumed to arise from 
fibrinogen during its conversion to fibrin, then it is always possible 
to express inhibitor concentration in terms of initial and final sub­
strate concentration. Integrating the rate equation for competitive 
inhibition between the limits of initial and final substrate concentra­
tion shows that inhibition in this system would not be detectable as 
deviation from the expected linear relationship. The same holds true 
for noncompetitive and uncompetitive inhibition as long as the inhibitor 
concentration can be expressed in terms of the constant initial and final 
substrate concentrations. Integration of both these rate equations would 
give the same form as observed for the competitive case. Product inhi­
bition occurring in a system which has only one measureable product con­
centration will not be detected by the assay techniques used here.
In the situation where inhibitor arises from proenzyme along 
with enzyme, the results are different. Here the kinetic assumptions 
fit the observed data. A calculated for the enzyme-inhibitor complex 
is 0.85 X 10"7 M, indicating a strong affinity between enzyme and hypo­
thetical inhibitor. Superficially, the process of developing inhibitor 
action along with enzyme from the same proenzyme seems inefficient and 
illogical. In this case, however, there may be some justification for 
. such a mechanism. The production of too much thrombin activity in
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response to a bruise or cut can be just as fatal as the production of 
none. Thrombus formation in the circulatory system is as likely to be 
terminal as unregulated hemorrhage. Internal regulation of thrombin 
activity could be an important aspect of homeostasis.
Wide intracellular distribution of (U) vitamin probably 
represents a combination of hydrophobic interactions and charge-transfer 
complex formation with proteins. Removal of most of the radioactivity 
by chloroform-methano1 extraction provides evidence that this material 
is probably not active in prothrombin synthesis. This evidence is based 
on the lack of ̂  vitro activity of vitamin except in liver slice 
(43) or perfused liver (22) experiments.
The presence of radioactive compounds in microsomes with an 
altered Rf value compared to vitamin indicates that some breakdown 
of the vitamin may be occurring in the microsomal membrane. The major 
metabolite, with an Rf approximating 2-methyl-l,4-napthoquinone, could 
be an intermediate in conversion of vitamin K to some active prosthetic 
group.
Lack of i£ vitro activity of vitamin K^, itself, in cell-free 
systems could be due to several factors. It could be due to the form in 
which the vitamin is supplied, or possibly to failure to provide condi­
tions adequate for a ̂  novo protein-synthesizing system. Some essential 
cofactor for vitamin K action could be lacking in the Ĵ n vitro system.
In considering these factors which could be preventing ̂  vitro 
activity of vitamin K]̂ , it should be said that if vitamin K acts in pro­
thrombin synthesis after having been degraded itself, then no information 
is available about such a metabolite. It is possible that reactions
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which degrade vitamin K are closely linked to reactions which bind the 
vitamin to proteins, and the free metabolite is never detected. Without 
the stereospecificity available in a protein bound complex it is diffi­
cult to see how vitamin K could specifically affect the synthesis of only 
one group of proteins. Bioassayable amounts of vitamin K have been found 
covalently bound to rat liver subcellular fractions (48). According to 
Hecker - Mueller (30), the types of covalent linkages existing between 
protein and vitamin K may be fairly varied. The 5,6,7,8-tetralin p-quinol 
is a structural analogue of the A and B rings of estradiol. It also bears 
a strong resemblance to the napthoquinone nucleus of the vitamin K series 
a fact which is not pointed out by the authors. There is a doubly inter­
esting involvement here, since female rats, or male rats fed sufficient 
estradiol are quite resistant to the symptoms of vitamin K deficiency (29).
The tetralin p-quinol is a product of the action of an NADPH- 
dependent microsomal mixed function oxidase on 5,6,7,8-tetrahydro-2- 
napthol. It is proposed that the mixed function oxidase produces oxygen 
free radicals which attack the tetrahydro-2-napthol, giving a free rad­
ical form which reacts with acceptor molecules. Acceptor molecules may 
be small molecules in the reaction environment, or protein of the system. 
Ability of p-chloromercuribenzoate and N-ethyl maleimide to inhibit the 
enzymic system suggest a requirement for SH groups in the radical gener­
ating or accepting system. It seems to be more than coincidence that 
metabolites of estradiol and vitamin K are both bound to microsomal pro­
tein by an NADPH-dependent microsomal mixed function oxidase, are struc­
turally related to a close degree and are both able to aid in prothrombin 
synthesis.
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The time dependent appearance of protein bound radioactivity 
could be thought of as support for a covalently bound functional form of 
the vitamin. Although a considerable amount of time is required to ob­
tain a large proportion of the label in the lipid insoluble fraction, it 
is possible that most of this non-extractable material is really non- 
specifically bound. Thus there is no evidence for a physiological role 
in binding which occurs after the deficient animal has synthesized enough 
prothrombin to restore the normal level of the blood. In its present 
form this data is not very helpful with regard to understanding vitamin 
K function.
At this point, discretion was considered to be the better part 
of valor, and a completely new approach was attempted. If the first 
approach has been based upon assumptions that intracellular location of 
the vitamin should help to reveal its mode of action, then the second 
attack assumes that something peculiar exists in the protein molecule 
affected by this vitamin.
The procedure used here for the preparation of prothrombin 
gives a product of good purity. The purity does not remain completely 
constant between preparations, as measured by specific enzyme activity, 
but this could be due to a slight degree of hemolysis in some of the 
plasma samples.
Calculation of an s value for the purest preparations
obtained gives a figure which is lower than the SgQ ^ values presented 
in the literature. Literature values range from 5.3 according to Seegers 
(49), down through 4.9 obtained by Lamy and Waugh (50), to a low of 4.6 
(51). Moore et al. (8) use the analytical ultracentrifuge as a tool to
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provide evidence for the homogeneity of their preparation, but no mention 
is made of an s value which could be obtained from their sedimentation 
runs.
It is possible that the difference in purity of different prep­
arations may have some effect on the s values. Seegers gives his values 
for specific activity in terms of Iowa units per mg tyrosine, and his 
best values correspond to 2200 Iowa units per mg protein. The prepara­
tion used in this preparation had a specific activity corresponding to 
2900 units per mg protein. Thus the data indicate that bovine prothrom­
bin may have a molecular weight in the region of 45,000 to 55,000, rather 
than 68,000.
The number of disulfide bonds present in the native molecule 
gives evidence for a complex structural situation. Evidence also exists 
for a complete dependence of enzyme activity upon the integrity of these 
disulfide bonds. Incubation with dithiothreitol at pH 7.0 and 0°C for 
24 hours gives destruction of half the clotting activity when dithiothre­
itol is present is present in a 0.5 fold stoichiometry compared with 
disulfide bonds If incubation is carried out at 24°C then all clotting 
activity is destroyed in 24 hours while at 37°C 99% of the activity is 
lost after two hours. Purified prothrombin can be incubated at 37°C for 
24 hours with no change in the clotting activity present.
Since the aim of this study lies more in elucidation of control 
mechanisms than in repeating the structural studies of others, consider­
ation has been given to the question of how the disulfide bonds pair 
correctly during the synthetic processes. Shapiro et al. (52) have pro­
posed a mechanism for subunit assembly in gamma globulin. Using mouse
84
plasma cell tumours, they found L chains to be synthesized more rapidly 
and in excess of H chains. Free L chains appeared in the cytoplasm of 
the tumour cells, but no free H chains were observed. The evidence indi­
cates that free L chains attach to H chains before the release of H's 
from the polyribosome complex. Thus correct configurational alignment 
and disulfide pairing are occurring during the translation process.
If the prothrombin molecule were composed of subunits, it could 
be proposed that vitamin K functions in the assembly of these subunits 
into native protein. The finding of a molecular weight of 48,000 for 
the species in 8 M urea and 1 x 10"^ M 2-mercaptoethanol rules out the 
possibility of any subunit structure in the native prothrombin molecule.
A precise molecular weight determination on the reduced prothrombin mole­
cule. A precise molecular weight determination on the reduced prothrom­
bin molecule requires a more complete study of concentration dependence 
of the SjQ ^ value, but the data conclusively show that native prothrom­
bin does not contain two or more identical thrombin precursor subunits.
If vitamin K cannot be involved in subunit assembly could it be involved 
with, tertiary structure formation? Two logical alternatives exist: (1)
primary amino acid sequence thermodynamically dictates correct disulfide 
pairing during or immediately after message translation, or, (2) some 
stereo-specific enzyme activity performs this function during or after 
polypeptide synthesis. If the formation of disulfide bonds occurs as in 
postulate (1), then this is positive evidence that vitamin K is not in­
volved in this step of prothrombin synthesis.
A precedent already exists for determining the effect of pri­
mary amino acid sequence on disulfide pairing. Rearrangement of randomly
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paired disulfide bonds in bovine pancreatic ribonuclease (46) can restore 
enzyme activity. Free sulfhydryl compounds, or a microsomal disulfide 
interchange system catalyse this rearrangement.
Observations made in this thesis suggest that systems which 
restore enzymic activity to randomly reoxidize ribonuclease are without 
effect on reduced prothrombin. The microsomal disulfide interchange 
system shows no activity, either with or without added dehydroascorbate. 
The effects of several oxidizing agents, including NAD, NADP, GSSG and 
DHA, are all negative. Reoxidation at neutral pH by exposure to air 
gives no restoration of prothrombin activity. All this negative evidence 
suggests that prothrombin does not have sufficient thermodynamic infor­
mation present in its primary structure to allow resumption of native 
conformation after disulfide reduction. What then of the possibility 
of a specific enzyme carrying out this function only in the prothrombin 
group of proteins? The final section of the preceding chapter deals 
with the characterization of such an activity in rat liver microsomal 
supemate.
Several difficulties inherent in assaying for this type of 
activity were apparent before the experiments were performed. Among 
these was the question of species specificity. Practical considerations 
ruled out the use of combinations other than rat liver enzyme and bovine 
prothrombin. A lack of rat blood available as a prothrombin source has 
discouraged any thoughts of preparing rat prothrombin. Bovine prothrom-
I
bin is only present at a concentration of 5 mg percent, and recovery 
procedures are generally not more than 50% efficient. Bovine liver was 
not used as an enzyme source due to the difficulty in manipulating rumin­
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ant nutritional status through dietary changes. It may be hoped that 
the lack of species specificity observed for this enzyme is relevant to 
the large number of species which require vitamin K for prothrombin syn­
thesis.
Another predictable difficulty in this system is the effect of 
concentration of reduced prothrombin on the theoretical yield obtained 
in the reoxidation reaction. If the RNase story is followed chronolog­
ically, it appears that Anfinsen started at a concentration of 2.0 mg of 
reduced ribonuclease per ml of reoxidation system in 1961 (46). In this 
paper there is no mention about the relative amount of reactivation ob­
served. In 1963 (53) he has used a standard concentration of 0.018 mg 
per ml of reoxidation system to get a 70% theoretical recovery of activ­
ity. By 1964 (54) the concentration of reduced material has dropped to 
as low as 0.009 mg per ml in systems which give complete theoretical 
recovery. Apparently protein concentration, or, perhaps more accurately 
reduced protein-SH concentration is quite critical in any reoxidation 
system. Recovery of native activity can be measureable, but meaningless, 
if it represents an insignificant proportion of the theoretical activity 
present.
The conditions required for a good theoretical recovery of 
activity are subject to limitations imposed by the minimum assayable 
enzyme concentration. However, with prothrombin the random formation 
of intermolecular disulfide bonds may not be the only problem. Decreas­
ing the protein concentration will only prevent incorrect intermolecular 
bond formation, not the improper intramolecular bonds which may be formed 
almost irreversibly in this case. It is possible that regulation of the
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oxidation potential of the system could give higher values for the maxi­
mum obtainable amount of enzymic reactivation.
The minimum assayable concentration of prothrombin is about
0.1 to 0.2 y per ml. The maximum recovery obtained on enzymic oxidation 
has been 12% at a concentration of 2.4 ̂  per ml of reoxidation system. 
Before assay this is diluted 1:1 to give only 1.2 jj of protein per ml 
in the assay. It seems that the limitations of the dilution process are 
imminent.
A critical assessment of the activation factor, of the product 
of its reaction with prothrombin, and of the reaction conditions strongly 
indicate that prothrombin activity is arising from oxidation of reduced 
prothrombin.
Preliminary observations relating activity of the AF enzyme 
with vitamin K nutritional status allow some speculation as to the regu­
latory function of vitamin K at the molecular level. Based on conclusive 
evidence that the primary site of regulation of prothrombin synthesis is 
really translation rather than transcription, the following model accounts 
for the facts known about the action of vitamin K.
Reading of prothrombin message ENA into prothrombin polypeptide 
requires that correct disulfide bond formation occur during the transla­
tion process. Without correct pairing, either enzymically inactive and 
immunologically inactive material is formed and released, or else the 
translation process just stops with incomplete polypeptide attached to 
the ribosome. Correct pairing requires an enzyme to align the SH groups 
properly, and the enzyme also functions as an electron acceptor in the 
oxidation of SH to disulfide bonds. This enzyme is required for correct
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formation of two or more of the disulfide linkages occurring in the 
native prothrombin molecule. In its absence, either synthesis of pro­
thrombin is halted before proceeding very far, or else the translation 
process occurs, but the product is inactive, and cannot be converted to 
native prothrombin even in the presence of enzyme. Vitamin K, or some 
metabolite of the vitamin is a cofactor in this enzyme, probably being 
reduced to the hydroquinone form by cysteine sulfhydryl groups, and then 
being reoxidized to the quinone form by oxygen.
The value of this model, like any other, lies in the types of 
creative thinking which it can produce, rather than in any absolute 
truth or untruth contained within. It is of necessity rather narrow and 
introspective. The specificity of the system under study demands this. 
Nevertheless, its principles reflect a logical continuity with the ideas 
of "molecular biology", and they may have implications for those inter­
ested in the regulation of protein biosynthesis.
CHAPTER V
SUMMARY
Vitamin K, given in large doses, is distributed uniformly among 
the liver subcellular fractions of both vitamin K deficient, and normal 
rats. In the short time interval between vitamin K administration to 
deficient animals, and initiation of prothrombin formation, most of the 
administered vitamin K is extractable with lipid solvents. Covalent 
binding of vitamin radioactivity to protein accounts for a consider­
able proportion of the recovered radioactivity only at a time period 
after the prothrombin level has returned to normal. The rather low 
specific activity of the vitamin used in the experiment does not allow 
a clear choice between requirements for covalent, or hydrophobic binding 
of the vitamin in the production of prothrombin.
Bovine prothrombin contains a minimum of eight disulfide bonds 
per molecule. DTNB provides an extremely sensitive assay method for the 
low concentration of sulfhydryl groups present after reduction of dilute 
protein solutions. Ionic environment about the free sulfhydryl groups 
may affect reactivity with DTNB, so the values obtained only represent 
a minimal number. Attempts to demonstrate the presence of subunits in 
the bovine prothrombin molecule have been unsuccessful.
Prothrombin which has undergone complete disulfide reduction
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does not regain any enzymic activity on atmospheric reoxidation. Common 
biological oxidants such as dehydroascorbic acid, oxidized glutathione 
NAD and NADP are ineffective in restoring enzyme activity when present 
in the reoxidation system. Incubation with a heat labile, non-dialysable 
fraction from rat liver microsomal supernatant can restore up to 10 per­
cent of the original activity of reduced bovine prothrombin. Initial 
purification of this activating factor has been carried out in an attempt 
to characterize its action. Rats which are severely depleted of vitamin 
K do not possess assayable amounts of activating factor.
It is proposed that vitamin K, or some metabolite of the vita­
min, may be a cofactor of the AF enzyme which is required in pairing and 
oxidizing sulfhydryl groups during prothrombin synthesis.
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